about
Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNAFusarium infections in immunocompromised patientsA mouse model for Candida glabrata hematogenous disseminated infection starting from the gut: evaluation of strains with different adhesion propertiesResponse of macrophage Toll-like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosisThe Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular TrapsInvasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitorsCryptococcal interactions with the host immune system.Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components.Agent-based modeling approach of immune defense against spores of opportunistic human pathogenic fungi.Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi.Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherenceMucosal damage and neutropenia are required for Candida albicans disseminationInsights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosisTherapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin.An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent.Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.Role of IL-17A on resolution of pulmonary C. neoformans infectionInfluence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantationNew avenues for phage-display library to produce a Cryptococcus-specific anti-idiotypic antibody of HM-1 killer toxin.Successful management of cryptococcosis of the bilateral adrenal glands and liver by unilateral adrenalectomy with antifungal agents: a case reportDual roles of CD40 on microbial containment and the development of immunopathology in response to persistent fungal infection in the lungFunctional genomic analysis of Candida glabrata-macrophage interaction: role of chromatin remodeling in virulence.Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosisDepletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by γδ T cells.Candidaemia and cancer: patients are not all the same.Hibernating little brown myotis (Myotis lucifugus) show variable immunological responses to white-nose syndrome.In vivo role of dendritic cells in a murine model of pulmonary cryptococcosisChemokine receptor 2-mediated accumulation of fungicidal exudate macrophages in mice that clear cryptococcal lung infection.A virtual infection model quantifies innate effector mechanisms and Candida albicans immune escape in human blood.Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps.Specific alterations in complement protein activity of little brown myotis (Myotis lucifugus) hibernating in white-nose syndrome affected sites.Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.Isolation and purification of antigenic components of CryptococcusThe relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response.Investigating the function of Ddr48p in Candida albicansThe Candida albicans ATO Gene Family Promotes Neutralization of the Macrophage PhagolysosomeAn anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice.Analysis of the Protein Kinase A-Regulated Proteome of Cryptococcus neoformans Identifies a Role for the Ubiquitin-Proteasome Pathway in Capsule Formation.Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides
P2860
Q24656078-860C57BC-530A-4EBB-832C-91964E7D8354Q24685627-37125AA5-B15B-414F-926D-39D6019114EDQ27310789-D89DF021-2196-40A5-B8E5-228C58EE4016Q28391724-79387154-FE3A-4D84-A6D4-1B056B012328Q28554057-CFF427D7-B400-4488-88C7-FC71573A7D41Q29302324-B96E5856-BD1D-4F09-92DA-4229A644DCD7Q30387948-9008F2C5-5420-4EA1-8AED-AA91FC4595A5Q30483673-8BA519FE-9D94-45ED-B2F2-1CAF90D68E8EQ30513831-7E275BD8-5727-4545-AF47-FF4AFBFAC823Q30833128-A6E40848-823C-49BF-98A0-04450DB995A9Q30862390-EA6DDCA2-7BC2-41C0-9E02-7C61D742C5D5Q33320189-F5626944-54B6-4095-B2CC-BBA5300B9166Q33499671-481B8D4D-100D-4FE8-8A71-E23790C7CFB6Q33613647-ABACC18F-4516-41B5-83DD-18DC65B1893DQ33816063-8FD4AD60-4AF3-46CD-9519-FC64BB5751A6Q33827914-5A25FC9C-4B87-4E3B-8258-65E3E473C875Q33832023-887BAF3E-5579-4DD3-A76C-A0C5DA6A0B74Q33869448-CE1A51CA-4489-4B8E-82CA-CD7599CBAC4AQ33902565-61DAFC41-F468-4C17-AA0B-93D59F802123Q34099989-451E8D4A-C1B6-4825-8D1D-6144E0A3801BQ34254509-9D7698EA-F6F2-4B3A-8D29-4AB5554FB85BQ34390528-70691796-B3E8-4518-8393-EADA36D88BE1Q34492622-5D91C3FB-6F45-4A37-9F17-2A86A324E89AQ34502561-7B33863E-7D02-43FF-A274-17392952A58AQ34521837-3FCAFE27-6CF8-4AE8-95ED-D998EFD46F32Q34634458-65E73B9A-FF8C-4006-A68F-B3BD32BCF529Q34721052-DFB54DE5-93C4-413F-8379-140A4A47F0B4Q34756043-0D8C71CE-34E2-4170-8538-F50F1B58EB8BQ35105573-1993EEDE-68EF-4552-8646-41E0A3253662Q35557248-0BED7857-536A-4B60-9959-96C96A7F2304Q35582719-52F7E1AF-D988-4717-A9F9-E0B4D8356A40Q35609334-993980DD-FB83-4FBE-9D98-69FF0F507724Q35813386-FE1B0007-1115-45FB-B9A6-06B67B87CC9DQ35913526-896E8390-EF17-4698-AEF4-83054256DA39Q36017815-91683D4B-06AA-4FA1-BFAA-9CFE0D1707E9Q36138048-949D1A2E-7D45-4AA7-ABB1-67242E2D51D1Q36313815-90834579-0E31-4C45-8F91-95153B5255EDQ36422137-F9BC52B2-C53C-4F04-8F63-22E203E0EC28Q36496545-7630E3D0-F9B2-4FAF-B5EF-F234982CCC2CQ36544402-CD19B3A9-5630-4E86-819F-D137F56CCA59
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The immune response to fungal infections.
@ast
The immune response to fungal infections.
@en
type
label
The immune response to fungal infections.
@ast
The immune response to fungal infections.
@en
prefLabel
The immune response to fungal infections.
@ast
The immune response to fungal infections.
@en
P2860
P1476
The immune response to fungal infections.
@en
P2093
Shmuel Shoham
Stuart M Levitz
P2860
P304
P356
10.1111/J.1365-2141.2005.05397.X
P407
P577
2005-06-01T00:00:00Z